Filter list by keyword
Show More
Show Less
to
of
Total
Sorry, no data available.
BME
Health Sciences Trust
Equity
You can trade this ETF now.
BME
Health Sciences Trust
- Market Price as of Nov 29, 2023 $37.91
- 1 Day Price Change as of Nov 29, 2023 0.00 (0.00%)
- Distribution Rate as of Nov 29, 2023 6.74%
- Premium Discount as of Nov 29, 2023 -6.42%
Overview
Investment Approach
BlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust utilizes an option writing (selling) strategy to enhance dividend yield.No assurance can be given that the Trust’s investment objective will be achieved.
ACCESS TO RESILIENCY AND GROWTH IN HEALTHCARE
Seeks to invest in healthcare companies with strong pipelines and potential long-term growth opportunities
DIVERSIFIED EXPOSURE ACROSS THE HEALTHCARE SECTOR
Access to the full spectrum of sector opportunities, investing across pharmaceuticals, biotechnology, medical devices and healthcare providers
SEEKS TO REDUCE PORTFOLIO VOLATILITY
Sells (writes) call options on underlying equity portfolio, potentially reducing the fund’s volatility
Performance
Performance
Growth of Hypothetical $10,000
Performance chart data not available for display.
NAV
Market Price
Source: Lipper. Data reflects different methodology from the BlackRock calculated returns in the Returns tab. The Growth of Hypothetical $10,000 chart reflects a hypothetical $10,000 investment in the fund. The chart uses NAV performance or market price performance and assumes reinvestment of dividends and capital gains. The chart assumes Fund expenses, including management fees and other expenses were deducted. The starting NAV for the NAV performance chart reflects a deduction of the sales charge from the initial public offering price.
Source: Lipper. Data reflects different methodology from the BlackRock calculated returns in the Returns tab. The $10,000 Hypothetical Over Time chart reflects a hypothetical $10,000 investment in the investor class of shares noted and does not assume the max sales charge. Had sales charge been included, returns would have been lower. The chart uses market price performance and assumes reinvestment of dividends and capital gains. Fund expenses, including 12b-1 fees, management fees and other expenses were deducted. Performance for other share classes will vary.